Mendlein John
CIK 0001238362
Director
Filings
11
Latest May 30, 2025
Issuers covered
2
Showing
11 of 11
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 40% | +0.4% | -1.0% | +18.3% | -23.0% |
| 90 days | 5 | 60% | +12.5% | +14.8% | +31.6% | -14.3% |
| 180 days | 5 | 60% | +9.8% | +12.0% | +28.7% | -11.9% |
| 365 days | 5 | 60% | +42.4% | +78.2% | +86.2% | -22.2% |
Issuers
Companies where Mendlein John has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| FATE | Fate Therapeutics Inc | 8 | May 30, 2025 |
| OMGA | Omega Therapeutics, Inc. | 3 | Jun 21, 2024 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|